A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to evaluate safety and tolerability of a single dose of MEDI8852 when given with oseltamivir, the safety and tolerability of oseltamivir alone, and the safety and tolerability of a single dose of MEDI8852 alone in adult participants with acute, uncomplicated influenza caused by Type A strains.
Epistemonikos ID: 72bff832b422af0ecd2f1cde1af2c9d62e84e7d2
First added on: May 12, 2024